<?xml version="1.0" encoding="UTF-8"?>
<p>Systemic chemotherapy is the main treatment option for advanced EPNEC. Some clinical guidelines for treating EPNEC recommend platinum‐based chemotherapy as the first‐line treatment.
 <xref rid="cas14811-bib-0006" ref-type="ref">
  <sup>6</sup>
 </xref>, 
 <xref rid="cas14811-bib-0007" ref-type="ref">
  <sup>7</sup>
 </xref> The response rate is approximately 30%‐50%; however, the PFS is only 4 or 5 months.
 <xref rid="cas14811-bib-0008" ref-type="ref">
  <sup>8</sup>
 </xref>, 
 <xref rid="cas14811-bib-0009" ref-type="ref">
  <sup>9</sup>
 </xref> The efficacy of platinum‐based chemotherapy for EPNEC is limited, and second‐line chemotherapy is necessary in one‐half of all cases.
 <xref rid="cas14811-bib-0008" ref-type="ref">
  <sup>8</sup>
 </xref>, 
 <xref rid="cas14811-bib-0009" ref-type="ref">
  <sup>9</sup>
 </xref>
</p>
